- Home
- NYXH
NYXH
Nyxoah SA
as 11-15-2024 4:00pm EST
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
| Founded: | 2009 | Country: | Belgium |
| Employees: | N/A | City: | N/A |
| Market Cap: | 261.1M | IPO Year: | 2021 |
| Target Price: | $17.00 | AVG Volume (30 days): | 26.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.00 - $20.00 | Next Earning Date: | 11-06-2024 |
| Revenue: | $5,668,079 | Revenue Growth: | 32.65% |
| Revenue Growth (this year): | 37.1% | Revenue Growth (next year): | 418.12% |
Latest Nyxoah SA News
NYXH Breaking Stock News: Dive into NYXH Ticker-Specific Updates for Smart Investing
GuruFocus.com
10 days ago
Nyxoah SA (NYXH) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
Zacks
11 days ago
Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates
GlobeNewswire
11 days ago
Nyxoah Reports Third Quarter Financial and Operating Results
GuruFocus.com
12 days ago
Nyxoah SA (NYXH) Q3 2024: Everything You Need To Know Ahead Of Earnings
GlobeNewswire
13 days ago
Nyxoah Appoints John Landry as Chief Financial Officer
Zacks
17 days ago
Privia Health (PRVA) Earnings Expected to Grow: Should You Buy?
Zacks
18 days ago
Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
GlobeNewswire
23 days ago
Publication relating to transparency notifications
Compare NYXH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NYXH Nyxoah SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.